Infectious Disease and Microbiology – Enterobacter Species

Overview

Enterobacter species are aerobic Gram-negative bacilli belonging to the Enterobacterales. They normally colonize the gastrointestinal tract but are important opportunistic and healthcare-associated pathogens.

Major infections include urinary tract infection, pneumonia, catheter-associated bacteremia, surgical-site infection, and neonatal meningitis.

Important Species

Species traditionally included in this group include:

• Enterobacter cloacae

• Enterobacter aerogenes

• Enterobacter sakazakii

• Enterobacter tayorae

• Other Enterobacter species

Some older names in this list have subsequently undergone taxonomic reclassification, but they may still appear in older microbiology references.

Microbiologic Characteristics

Enterobacter species are:

• Gram-negative bacilli

• Aerobic/facultatively anaerobic organisms

• Members of the Enterobacterales

• Common colonizers of the gastrointestinal tract

Their ability to acquire and express multiple mechanisms of antimicrobial resistance makes them important hospital pathogens.

Incubation Period

The incubation period is:

Unknown or not clearly defined

Because many infections arise from the patient’s own colonizing flora, a conventional exposure-to-disease incubation period is often difficult to establish.

Epidemiology

Enterobacter species may form part of the normal enteric flora.

Many infections are endogenous, meaning that the infecting strain originates from organisms that have already colonized the patient’s gastrointestinal tract.

Nosocomial Transmission

Enterobacter species are particularly important causes of healthcare-associated infections.

Hospital outbreaks have demonstrated that transmission may also occur through:

• Person-to-person spread

• Contaminated medical equipment or materials

• Common contaminated sources

• Contaminated intravenous solutions

Thus, infection is not always derived exclusively from the patient’s own intestinal flora.

Risk Factors

Infection is especially associated with patients who are:

• Hospitalized

• Critically ill

• Immunocompromised

• Receiving broad-spectrum antibiotics

• Using urinary or vascular catheters

• Mechanically ventilated

• Recently undergoing surgery

Urinary Tract Infection

Enterobacter species can cause healthcare-associated urinary tract infections, particularly in patients with urinary instrumentation or indwelling catheters.

Manifestations range from cystitis to complicated urinary infection and urosepsis.

Pulmonary Infection

These organisms can cause hospital-acquired pneumonia, particularly in critically ill or mechanically ventilated patients.

Pulmonary infection may progress to bacteremia and sepsis in severe cases.

Catheter-Associated Bacteremia

Enterobacter species are important causes of catheter-associated bloodstream infection.

An intravascular catheter may become colonized and serve as a persistent source of bacteremia.

Management may therefore require both appropriate antimicrobial therapy and evaluation for catheter removal.

Contaminated Intravenous Infusions

Hospital outbreaks have occasionally resulted from contaminated intravenous solutions or infusions.

This can expose multiple patients to the same organism and produce clusters of bloodstream infections.

Surgical Wound Infection

Enterobacter species may infect surgical wounds, particularly in hospitalized patients with prolonged healthcare exposure or prior antimicrobial treatment.

Such infections may be polymicrobial.

Neonatal Meningitis

Some organisms historically classified within this group have been associated with neonatal meningitis.

A particularly important organism in older terminology is Enterobacter sakazakii, now classified as Cronobacter sakazakii.

Cronobacter is especially associated with severe infections in neonates, including meningitis and sepsis.

Diagnosis

Diagnosis is established by culture of the pathogen from an appropriate clinical specimen.

Depending on the infection, specimens may include:

• Blood

• Urine

• Respiratory secretions

• Cerebrospinal fluid

• Surgical wound material

• Catheter-associated specimens

Antimicrobial susceptibility testing is especially important because resistance patterns can be complex.

Antimicrobial Resistance

A major clinical feature of several Enterobacter species, particularly the Enterobacter cloacae complex, is the potential for clinically significant AmpC β-lactamase production.

AmpC can confer resistance to multiple β-lactam antibiotics and may complicate treatment.

Resistance may emerge during therapy with certain cephalosporins even when the initial laboratory isolate appears susceptible.

Treatment

The source lists several treatment options, including:

• Carbapenems, such as imipenem or meropenem

• Piperacillin–tazobactam

• Fluoroquinolones

However, because antimicrobial resistance varies considerably, treatment of serious Enterobacter infection should be based on the species, infection site, severity, and susceptibility results.

Additional Treatment Options

The source also lists:

• Third-generation cephalosporins

• Aztreonam

• Aminoglycosides

However, the possibility of AmpC-mediated resistance is particularly important when considering some β-lactams for serious Enterobacter infections.

Therefore, older treatment lists should not be interpreted as universally appropriate empiric choices.

Source Control

Management of invasive infection may require source control in addition to antibiotics.

Examples include:

• Removal of an infected vascular catheter

• Drainage of an abscess

• Management of an infected surgical site

• Removal or replacement of contaminated devices when appropriate

High-Yield Clinical Pattern

Hospitalized or critically ill patient

• ●

Urinary catheter, central line, mechanical ventilation, or recent surgery

• ●

Gram-negative bacillus causing UTI, pneumonia, or bacteremia

• ●

Potential AmpC β-lactamase-mediated resistance

→ Think Enterobacter species

Important Taxonomy Pearl

Older microbiology references may use:

Enterobacter aerogenes → now Klebsiella aerogenes

Enterobacter sakazakii → now Cronobacter sakazakii

Recognizing these older names can be useful when reviewing historical infectious-disease literature.

Exam Essentials

Genus: Enterobacter

Type: Gram-negative bacillus

Normal habitat: Gastrointestinal flora

Major setting: Nosocomial/healthcare-associated infection

Transmission: Endogenous flora, person-to-person spread, or contaminated common sources

Major infections: UTI, pneumonia, bacteremia, surgical-site infection

Important device association: Intravascular and urinary catheters

Diagnosis: Culture + antimicrobial susceptibility testing

Important resistance mechanism: AmpC β-lactamase in clinically important species such as the E. cloacae complex

Treatment: Susceptibility-guided antimicrobial therapy; serious resistant infections may require agents such as carbapenems

Older name: E. aerogenes → Klebsiella aerogenes

Older name: E. sakazakii → Cronobacter sakazakii

Key clinical pearl: Enterobacter species are important hospital-acquired Gram-negative pathogens, and the major treatment consideration is their potential for AmpC-mediated β-lactam resistance, making culture and susceptibility testing essential when selecting therapy for serious infection.

Infectious Disease and Microbiology – Nonpathogenic Entamoeba Species

Overview

Several Entamoeba species may colonize the human gastrointestinal tract without producing clinically significant disease. Important examples include Entamoeba coli, Entamoeba hartmanni, and Entamoeba polecki.

These organisms are generally considered nonpathogenic intestinal protozoa and should not be confused with Entamoeba histolytica, which causes invasive amebiasis.

Important Species

The principal species in this group include:

• Entamoeba coli

• Entamoeba hartmanni

• Entamoeba polecki

These species are usually detected incidentally during parasitologic stool examination.

Microbiologic Characteristics

These Entamoeba species are protozoa that may inhabit the human intestinal tract.

The most important microbiologic distinction is:

Nonpathogenic Entamoeba species ≠ Entamoeba histolytica

E. histolytica is capable of tissue invasion and may cause intestinal and extraintestinal amebiasis, whereas E. coli, E. hartmanni, and E. polecki generally do not cause invasive disease.

Epidemiology

These nonpathogenic Entamoeba species have a worldwide distribution.

They may be detected in individuals from many geographic regions, particularly where exposure to fecally contaminated food or water occurs.

Clinical Significance

Most individuals carrying these organisms are asymptomatic.

Therefore, finding one of these Entamoeba species in a stool specimen usually represents intestinal colonization rather than active disease.

Possible Diarrhea

Although these organisms are generally considered nonpathogenic, some experts have suggested that they may rarely be associated with diarrhea.

However, when diarrhea occurs in a patient carrying one of these organisms, other causes should generally be investigated before attributing the symptoms to the Entamoeba species.

Distinction from Entamoeba histolytica

This distinction is particularly important for examinations and clinical interpretation.

E. histolytica

→ Pathogenic

→ Causes amebic colitis/dysentery

→ Can invade intestinal tissue

→ May disseminate to the liver and cause amebic liver abscess

E. coli, E. hartmanni,

and

E. polecki

→ Generally nonpathogenic

→ Usually asymptomatic

→ Typically represent intestinal colonization

→ Usually require no treatment

Entamoeba coli

Entamoeba coli is a nonpathogenic intestinal amoeba.

Importantly, Entamoeba coli is a protozoan and is completely different from Escherichia coli, the Gram-negative bacterium commonly abbreviated E. coli.

This distinction is a frequent source of confusion.

Diagnosis

Diagnosis is based on parasitologic examination of stool specimens.

Microscopic examination can demonstrate trophozoites or cyst forms and help distinguish nonpathogenic Entamoeba species from pathogenic E. histolytica.

Accurate identification is important because treatment requirements differ substantially.

Treatment

For uncomplicated colonization with these nonpathogenic Entamoeba species:

No treatment is usually required.

Their presence alone is not an indication for antiparasitic therapy.

Additional Treatment

The source describes treatment for the unusual patient who has:

An Entamoeba species detected

• ●

Persistent diarrhea

• ●

No other identifiable cause

Possible regimens described include:

Metronidazole 500 mg orally every 8 hours for 6 days

or

Tinidazole 1 g orally every 12 hours for 3 days

Because these organisms are generally regarded as nonpathogenic, treatment should not automatically follow a positive stool finding.

High-Yield Clinical Pattern

Protozoan detected in stool

• ●

Identified as E. coli, E. hartmanni, or E. polecki

• ●

No invasive intestinal disease

→ Think nonpathogenic Entamoeba colonization

Exam Essentials

Genus: Entamoeba

Species: E. coli, E. hartmanni, E. polecki

Type: Protozoa

Distribution: Worldwide

Usual pathogenicity: Nonpathogenic

Typical clinical course: Asymptomatic

Possible association: Rare diarrhea, although causality is uncertain

Diagnosis: Parasitologic stool examination

Routine treatment: None required

Critical distinction: Do not confuse with Entamoeba histolytica

E. histolytica: Causes invasive amebiasis

Key clinical pearl: Entamoeba coli, E. hartmanni, and E. polecki are generally nonpathogenic intestinal protozoa, so their detection in stool usually does not require treatment; the crucial clinical task is distinguishing them from pathogenic E. histolytica.

Infectious Disease and Microbiology – Endolimax nana

Overview

Endolimax nana is an intestinal protozoan with a worldwide distribution. It is generally regarded as a nonpathogenic commensal organism rather than a cause of gastrointestinal disease.

Its presence in stool usually reflects colonization rather than clinically significant infection.

Microbiologic Characteristics

Endolimax nana is a protozoan parasite that can inhabit the human intestinal tract.

Unlike pathogenic intestinal protozoa such as Entamoeba histolytica, E. nana is not considered an invasive or disease-producing organism.

Epidemiology

E. nana occurs worldwide.

It may be detected incidentally during stool examination, including in individuals who have no gastrointestinal symptoms.

Clinical Significance

Endolimax nana is generally considered nonpathogenic.

Therefore, detection of the organism does not usually explain symptoms such as diarrhea or abdominal pain.

If a symptomatic patient is found to have E. nana, other infectious or noninfectious causes of the symptoms should be considered.

Commensal Nature

The organism behaves primarily as a commensal intestinal protozoan.

This means it may live in the gastrointestinal tract without causing tissue invasion or clinically important disease.

Diagnosis

Diagnosis is based on parasitologic examination of concentrated stool specimens.

Characteristic protozoal forms may be identified microscopically.

Treatment

No treatment is required.

Because E. nana is considered nonpathogenic, antimicrobial or antiparasitic therapy is generally unnecessary.

High-Yield Clinical Pattern

Protozoan detected on stool examination

• ●

Patient has no symptoms or symptoms are better explained by another cause

• ●

Organism identified as Endolimax nana

→ Think nonpathogenic intestinal commensal

Exam Essentials

Organism: Endolimax nana

Type: Protozoan

Distribution: Worldwide

Pathogenicity: Nonpathogenic

Clinical role: Intestinal commensal

Diagnosis: Concentrated stool examination

Treatment: None required

Key clinical pearl: Finding Endolimax nana in stool usually represents nonpathogenic intestinal colonization, so treatment is not indicated and another cause should be sought if gastrointestinal symptoms are present.

Infectious Disease and Microbiology – Encephalitis Viruses of the Flaviviridae Family

Overview

Several members of the Flaviviridae family, particularly the genus Flavivirus, are arthropod-borne viruses (arboviruses) capable of causing encephalitis. These viruses are transmitted mainly by mosquitoes, although the broader group of arboviral encephalitides also includes tick-borne infections.

Important mosquito-borne flaviviral encephalitis viruses include Japanese encephalitis virus, Kunjin virus, Murray Valley encephalitis virus, St. Louis encephalitis virus, and Rocio virus.

Classification of Arboviral Encephalitis

Arthropod-borne viral encephalitides can broadly be considered according to their vectors, including:

• Mosquito-borne arboviral encephalitis

• Tick-borne arboviral encephalitis

Mosquito-borne encephalitis viruses belong to several different viral families or groups.

Major Groups of Mosquito-Borne Encephalitis Viruses

Important mosquito-borne encephalitis viruses include:

Alphaviruses

• Eastern equine encephalitis virus

• Western equine encephalitis virus

Bunyavirus-related viruses

• La Crosse virus

• California encephalitis virus

• Jamestown Canyon virus

• Snowshoe hare virus

Flaviviruses

• Japanese encephalitis virus

• Kunjin virus

• Murray Valley encephalitis virus

• St. Louis encephalitis virus

• Rocio virus

Microbiologic Characteristics

Flaviviruses associated with encephalitis are:

• Single-stranded RNA viruses

• Positive-sense RNA viruses

• Approximately spherical

• Enveloped

The presence of a lipid envelope distinguishes them from naked RNA viruses such as enteroviruses.

Incubation Period

The incubation period is generally approximately:

5–15 days

The exact interval varies according to the particular virus and host factors.

Epidemiology

Flaviviral encephalitis is relatively uncommon, although outbreaks can occur in endemic regions.

Transmission patterns depend heavily on:

• Geographic location

• Mosquito-vector distribution

• Climate and season

• Animal reservoirs

• Human exposure to mosquito habitats

Transmission

These encephalitis viruses are generally transmitted through the bite of an infected mosquito.

The virus is maintained in nature through transmission cycles involving mosquitoes and animal reservoirs.

Humans are often incidental hosts rather than essential components of the natural transmission cycle.

Clinical Infection

Flaviviruses can cause epidemic outbreaks of encephalitis.

Many infections may be asymptomatic or produce only a nonspecific febrile illness, while a smaller proportion progress to neurologic disease.

Encephalitis

When the central nervous system becomes involved, patients may develop:

• Fever

• Severe headache

• Altered mental status

• Confusion

• Behavioral changes

• Seizures

• Reduced level of consciousness

Severe disease may progress to coma or death.

Neurologic Manifestations

Depending on the specific flavivirus and severity of infection, neurologic manifestations may include:

• Encephalitis

• Meningoencephalitis

• Tremor

• Abnormal movements

• Weakness

• Seizures

• Altered consciousness

Survivors of severe encephalitis may occasionally have persistent neurologic deficits.

Japanese Encephalitis Virus

Japanese encephalitis virus (JEV) is one of the most important mosquito-borne causes of viral encephalitis in endemic areas of Asia.

Most infections are asymptomatic, but symptomatic neuroinvasive disease can be severe.

A major distinguishing feature is the availability of an effective vaccine.

St. Louis Encephalitis Virus

St. Louis encephalitis virus is another mosquito-borne flavivirus capable of causing outbreaks of encephalitis.

Neurologic disease tends to be more clinically significant in older adults.

Kunjin Virus

Kunjin virus is a flavivirus associated particularly with Australia.

It can produce febrile illness and, less commonly, encephalitis.

It is now generally regarded as a subtype/variant within the West Nile virus group.

Murray Valley Encephalitis Virus

Murray Valley encephalitis virus is a mosquito-borne flavivirus associated predominantly with Australia and surrounding regions.

Although infection is uncommon, neurologic disease can be severe.

Rocio Virus

Rocio virus is a mosquito-borne flavivirus historically associated with outbreaks of encephalitis in Brazil.

Human infection is uncommon but can result in significant neurologic disease.

Diagnosis

Traditional diagnostic methods include:

• Cell culture

• Serologic testing

Serology is particularly useful for demonstrating virus-specific antibodies.

Molecular Diagnosis

PCR can be used to detect viral genetic material in appropriate clinical specimens.

The choice of PCR, serology, and specimen type depends on the particular virus and the timing of specimen collection.

Treatment

Treatment is primarily supportive and symptomatic.

Management of severe encephalitis may include:

• Maintenance of airway and ventilation

• Fluid and electrolyte management

• Treatment of seizures

• Management of increased intracranial pressure when present

• Intensive supportive care for severe neurologic disease

Antiviral Therapy

For the flaviviral encephalitides described here, the source notes:

No specific antiviral treatment is available.

Management therefore focuses on supportive care and prevention of complications.

Prevention

The major preventive strategy is to avoid mosquito bites.

Measures include:

• Appropriate insect repellents

• Protective clothing

• Mosquito nets when appropriate

• Window and door screens

• Reduction of mosquito breeding sites

• Following local vector-control recommendations

Japanese Encephalitis Vaccination

Unlike most other mosquito-borne encephalitis viruses in this group, Japanese encephalitis can be prevented by vaccination.

Vaccination may be recommended for travelers whose itinerary, duration of travel, season, and activities create a meaningful risk of exposure in endemic areas.

The source particularly emphasizes vaccination for long-term travelers staying in rural endemic areas.

High-Yield Clinical Pattern

Recent mosquito exposure in an endemic region

• ●

Acute fever

• ●

Altered mental status ± seizures or other neurologic abnormalities

• ●

Serologic or molecular evidence of flavivirus infection

→ Consider flaviviral encephalitis

Japanese Encephalitis High-Yield Pattern

Travel or residence in endemic Asia

• ●

Mosquito exposure, particularly in rural areas

• ●

Acute encephalitis

→ Think Japanese encephalitis virus

Major prevention clue → Vaccine available

Exam Essentials

Group: Flavivirus

Family: Flaviviridae

Genome: Positive-sense single-stranded RNA

Envelope: Present

Shape: Approximately spherical

Vector: Primarily mosquitoes for the viruses discussed here

Incubation: Approximately 5–15 days

Major manifestation: Encephalitis/meningoencephalitis

Epidemiology: Usually uncommon, but outbreaks occur

Important viruses: Japanese encephalitis, Kunjin, Murray Valley encephalitis, St. Louis encephalitis, and Rocio viruses

Diagnosis: Serology, PCR, and historically viral culture

Treatment: Supportive

Routine specific antiviral therapy: None

General prevention: Avoid mosquito bites

Vaccine-preventable member: Japanese encephalitis virus

Key clinical pearl: Mosquito-borne flaviviruses are enveloped, positive-sense single-stranded RNA viruses that can cause epidemic encephalitis; Japanese encephalitis is especially important because an effective vaccine is available for people with appropriate exposure risk.

Infectious Disease and Microbiology – Diphyllobothrium Species

Overview

Diphyllobothrium species are cestode helminths (tapeworms) acquired through consumption of raw or inadequately cooked infected fish. Infection is commonly called diphyllobothriasis and is usually asymptomatic.

Important species include D. dalliae, D. dendriticum, D. latum, D. pacificum, and D. ursi. D. latum is classically known as the broad fish tapeworm.

Microbiologic Characteristics

Diphyllobothrium species are cestodes, or segmented tapeworms.

Adult worms inhabit the human small intestine and consist of numerous segments called proglottids.

Eggs produced by the adult parasite are subsequently passed in the stool.

Incubation Period

Approximately 3–6 weeks may pass between ingestion of infected fish and the appearance of parasite eggs in the stool.

However, clinical manifestations may not develop until months or even years later, particularly when the infection persists.

Epidemiology

Diphyllobothriasis is strongly associated with regions where raw or inadequately cooked fish is traditionally consumed.

Historically, infection has been especially associated with lake regions and populations with dietary practices that increase exposure to infected fish.

Transmission

Humans acquire infection by eating raw or undercooked fish containing infective larvae.

The infection is not transmitted directly from one person to another because the parasite requires intermediate hosts to complete its life cycle.

Life Cycle

The life cycle requires two intermediate hosts.

Human/fish-eating mammal → eggs passed in feces → freshwater → copepod → freshwater fish → human

The first intermediate host is a freshwater copepod, historically described from genera such as Cyclops and Diaptomus.

Second Intermediate Host

Freshwater fish become the second intermediate host after consuming infected copepods.

Fish associated with transmission include:

• Salmon

• Perch

• Pike

• Other susceptible fish species

Humans and other fish-eating mammals become infected when they consume infected fish without adequate cooking.

Clinical Infection

Most Diphyllobothrium infections are asymptomatic.

The adult tapeworm can persist within the intestine for prolonged periods without causing significant disease.

Gastrointestinal Manifestations

Heavy infections may occasionally produce:

• Abdominal discomfort

• Diarrhea

• Nausea or other nonspecific gastrointestinal symptoms

These manifestations are generally more likely when the intestinal worm burden is substantial.

Intestinal and Biliary Obstruction

Rarely, a large worm burden may result in mechanical complications such as:

• Intestinal obstruction

• Biliary obstruction

These are unusual manifestations.

Vitamin B12 Deficiency

One of the most important associations is vitamin B12 deficiency, classically associated with D. latum.

The parasite can compete with the human host for vitamin B12 within the intestine.

Only a minority of infected individuals develop clinically significant deficiency.

Megaloblastic Anemia

Significant vitamin B12 depletion may eventually cause megaloblastic anemia.

Possible findings include:

• Macrocytosis

• Fatigue

• Weakness

• Pallor

• Low serum vitamin B12

Severe or prolonged deficiency can potentially produce neurologic manifestations associated with vitamin B12 deficiency.

Diagnosis

Diagnosis is primarily based on stool examination.

Macroscopic stool examination may reveal characteristic proglottids.

Microscopic examination of concentrated stool specimens can demonstrate parasite eggs.

Treatment

The preferred treatment described in the source is:

Praziquantel 10–20 mg/kg orally as a single dose

Treatment is generally highly effective.

Alternative Treatment

An alternative is:

Niclosamide 2 g orally as a single dose

Niclosamide tablets should be thoroughly chewed before swallowing.

Management of Vitamin B12 Deficiency

Patients with documented vitamin B12 deficiency should receive appropriate vitamin B12 replacement in addition to treatment of the parasitic infection.

Correction of the underlying infection prevents continued parasite-associated depletion.

Prevention

The primary preventive measure is:

Avoid eating raw or inadequately cooked fish.

Adequate preparation of fish prevents ingestion of viable infective larvae.

High-Yield Clinical Pattern

History of eating raw or undercooked fish

• ●

Tapeworm eggs or proglottids in stool

• ●

Vitamin B12 deficiency or megaloblastic anemia

→ Think Diphyllobothrium infection

Exam Essentials

Genus: Diphyllobothrium

Type: Cestode (tapeworm)

Classic species: D. latum

Common name: Broad fish tapeworm

Transmission: Raw or undercooked infected fish

First intermediate host: Copepod

Second intermediate host: Fish

Direct person-to-person transmission: No

Usual clinical course: Asymptomatic

Possible symptoms: Abdominal discomfort and diarrhea

Rare complications: Intestinal or biliary obstruction

Classic nutritional complication: Vitamin B12 deficiency → megaloblastic anemia

Diagnosis: Proglottids or eggs in stool

Treatment: Single-dose praziquantel

Alternative: Niclosamide

Prevention: Properly cook fish

Key clinical pearl: The classic association is raw freshwater fish → Diphyllobothrium tapeworm infection → vitamin B12 deficiency → megaloblastic anemia.

Infectious Disease and Microbiology – Dientamoeba fragilis

Overview

Dientamoeba fragilis is an intestinal protozoan found worldwide. Infection is frequently asymptomatic, although some infected individuals develop gastrointestinal symptoms, particularly abdominal pain and diarrhea.

Despite its name and intestinal location, D. fragilis should not be confused with Entamoeba histolytica, the invasive protozoan responsible for amebiasis.

Microbiologic Characteristics

Dientamoeba fragilis is a protozoan parasite that inhabits the human gastrointestinal tract.

Important characteristics include:

• Intestinal protozoan

• Usually identified in its trophozoite form

• Does not cause the invasive amebiasis associated with E. histolytica

Epidemiology

D. fragilis has a worldwide distribution.

The organism can be detected in both symptomatic and asymptomatic individuals, which can make determining its clinical significance challenging in some patients.

Clinical Infection

Most infections are asymptomatic.

When symptomatic disease occurs, gastrointestinal manifestations predominate.

Abdominal Pain

Abdominal discomfort or pain is one of the principal symptoms associated with D. fragilis infection.

The severity and duration can vary considerably among affected individuals.

Diarrhea

Some patients develop diarrhea, which may occur alone or together with abdominal pain.

Other nonspecific gastrointestinal complaints may accompany symptomatic infection.

Distinction from Entamoeba histolytica

An important microbiologic distinction is:

Dientamoeba fragilis ≠ Entamoeba histolytica

E. histolytica causes amebiasis, which can produce invasive colitis and extraintestinal disease such as liver abscess.

D. fragilis, in contrast, is generally associated with asymptomatic intestinal colonization or relatively mild gastrointestinal symptoms.

Diagnosis

Traditional diagnosis is based on microscopic examination of stool specimens.

Diagnostic techniques include:

• Direct stool examination

• Ferrous hematoxylin staining

Because trophozoites can be difficult to recognize, appropriately collected and processed stool specimens are important.

Molecular Diagnosis

Where available, PCR-based stool testing can provide sensitive detection of D. fragilis and may be incorporated into multiplex gastrointestinal parasite testing.

However, a positive result should be interpreted together with the patient’s symptoms because asymptomatic carriage occurs.

Treatment

Treatment is generally considered for patients with compatible gastrointestinal symptoms when D. fragilis is believed to be responsible.

One regimen described in the source is:

Paromomycin 500 mg orally every 8 hours for 7 days

Iodoquinol

Another treatment regimen is:

Iodoquinol 650 mg orally every 8 hours for 20 days

Additional Treatment Options

Other agents historically used include:

Tetracycline for approximately 7–10 days

or

Metronidazole for approximately 7 days

Treatment selection depends on patient factors, availability, tolerance, and the clinical significance of the detected organism.

Asymptomatic Infection

Because D. fragilis frequently occurs without symptoms, detection of the organism does not necessarily establish it as the cause of gastrointestinal complaints.

The decision to treat should therefore consider:

• Presence and severity of symptoms

• Alternative causes of diarrhea or abdominal pain

• Persistence of symptoms

• Other organisms detected in stool

High-Yield Clinical Pattern

Abdominal pain and/or diarrhea

• ●

Intestinal protozoan detected in stool

• ●

No evidence of invasive amebiasis

→ Consider Dientamoeba fragilis

Exam Essentials

Organism: Dientamoeba fragilis

Type: Protozoan parasite

Distribution: Worldwide

Most common course: Asymptomatic infection

Possible symptoms: Abdominal pain and diarrhea

Important distinction: Not Entamoeba histolytica

Traditional diagnosis: Direct stool examination + ferrous hematoxylin stain

Modern diagnostic option: Stool PCR

Treatment options: Paromomycin or iodoquinol

Additional historical therapies: Tetracycline or metronidazole

Key clinical pearl: Dientamoeba fragilis is a worldwide intestinal protozoan that is often asymptomatic but may cause abdominal pain and diarrhea; it should not be confused with the invasive amebiasis caused by Entamoeba histolytica.

Microbiologic Characteristics Dientamoeba fragilis is a protozoan parasite that inhabits the human gastrointestinal tract. Important characteristics include: • Intestinal protozoan

• Usually identified in its trophozoite form

• Does not cause the invasive amebiasis associated with E. histolytica

Epidemiology D. fragilis has a worldwide distribution. The organism can be detected in both symptomatic and asymptomatic individuals, which can make determining its clinical significance challenging in some patients.

Clinical Infection Most infections are asymptomatic. When symptomatic disease occurs, gastrointestinal manifestations predominate.

Abdominal Pain Abdominal discomfort or pain is one of the principal symptoms associated with D. fragilis infection. The severity and duration can vary considerably among affected individuals.

Diarrhea Some patients develop diarrhea, which may occur alone or together with abdominal pain. Other nonspecific gastrointestinal complaints may accompany symptomatic infection.

Distinction from Entamoeba histolytica An important microbiologic distinction is: Dientamoeba fragilis ≠ Entamoeba histolytica E. histolytica causes amebiasis, which can produce invasive colitis and extraintestinal disease such as liver abscess. D. fragilis, in contrast, is generally associated with asymptomatic intestinal colonization or relatively mild gastrointestinal symptoms.

Diagnosis Traditional diagnosis is based on microscopic examination of stool specimens. Diagnostic techniques include: • Direct stool examination

• Ferrous hematoxylin staining Because trophozoites can be difficult to recognize, appropriately collected and processed stool specimens are important.

Molecular Diagnosis Where available, PCR-based stool testing can provide sensitive detection of D. fragilis and may be incorporated into multiplex gastrointestinal parasite testing. However, a positive result should be interpreted together with the patient’s symptoms because asymptomatic carriage occurs.

Treatment Treatment is generally considered for patients with compatible gastrointestinal symptoms when D. fragilis is believed to be responsible. One regimen described in the source is: Paromomycin 500 mg orally every 8 hours for 7 days

Iodoquinol Another treatment regimen is: Iodoquinol 650 mg orally every 8 hours for 20 days

Additional Treatment Options Other agents historically used include: Tetracycline for approximately 7–10 days or Metronidazole for approximately 7 days Treatment selection depends on patient factors, availability, tolerance, and the clinical significance of the detected organism.

Asymptomatic Infection Because D. fragilis frequently occurs without symptoms, detection of the organism does not necessarily establish it as the cause of gastrointestinal complaints. The decision to treat should therefore consider: • Presence and severity of symptoms

• Alternative causes of diarrhea or abdominal pain

• Persistence of symptoms

• Other organisms detected in stool

High-Yield Clinical Pattern Abdominal pain and/or diarrhea  ●  Intestinal protozoan detected in stool  ●  No evidence of invasive amebiasis → Consider Dientamoeba fragilis

Exam Essentials Organism: Dientamoeba fragilis

Type: Protozoan parasite

Distribution: Worldwide

Most common course: Asymptomatic infection

Possible symptoms: Abdominal pain and diarrhea

Important distinction: Not Entamoeba histolytica

Traditional diagnosis: Direct stool examination + ferrous hematoxylin stain

Modern diagnostic option: Stool PCR

Treatment options: Paromomycin or iodoquinol

Additional historical therapies: Tetracycline or metronidazole

Key clinical pearl: Dientamoeba fragilis is a worldwide intestinal protozoan that is often asymptomatic but may cause abdominal pain and diarrhea; it should not be confused with the invasive amebiasis caused by Entamoeba histolytica.

Infectious Disease and Microbiology – Dicrocoelium dendriticum

Overview

Dicrocoelium dendriticum is a trematode helminth, commonly referred to as the lancet liver fluke. Human infection is rare and is usually asymptomatic, although the parasite may occasionally involve the biliary tract and cause symptoms such as biliary colic.

Microbiologic Characteristics

D. dendriticum is a trematode (fluke) that primarily inhabits the biliary system of its usual mammalian hosts.

Human infection is unusual and generally occurs accidentally.

Epidemiology

Dicrocoelium dendriticum has a worldwide distribution, but true human infection is rare.

Its eggs may sometimes be identified in human stool specimens without indicating genuine infection.

Spurious Passage of Eggs

A particularly important point is that eggs of D. dendriticum may appear in stool after a person eats infected animal liver.

In this situation, the parasite has not established infection in the patient. The eggs are simply passing through the gastrointestinal tract.

Therefore, detection of D. dendriticum ova in stool does not always prove true human parasitism.

Clinical Infection

Most true infections are asymptomatic.

When symptoms occur, they are usually related to the biliary tract and may include:

• Right upper quadrant discomfort

• Intermittent biliary pain

• Biliary colic

Symptomatic disease is exceptional.

Diagnosis

Diagnosis is based on parasitologic examination of stool specimens for characteristic eggs.

Because false-positive or spurious egg passage can occur, stool findings should be interpreted together with the clinical picture and dietary history.

Repeated stool examinations may help distinguish true infection from transient passage after ingestion of infected animal liver.

Treatment

Treatment is generally unnecessary in asymptomatic patients.

For the rare patient with symptomatic infection in whom other causes of biliary symptoms have been excluded, the source recommends:

Praziquantel 25 mg/kg orally every 8 hours for 3 doses

High-Yield Clinical Pattern

Dicrocoelium eggs found in stool

• ●

No compatible symptoms

• ●

Recent ingestion of animal liver

→ Consider spurious passage rather than true infection

Exam Essentials

Organism: Dicrocoelium dendriticum

Type: Trematode helminth

Common name: Lancet liver fluke

Distribution: Worldwide

Human infection: Rare

Typical course: Usually asymptomatic

Possible manifestation: Biliary colic

Diagnosis: Stool parasitologic examination

Important pitfall: Eggs in stool may represent spurious passage after eating infected animal liver

Treatment for symptomatic true infection: Praziquantel

Key clinical pearl: Finding Dicrocoelium dendriticum eggs in stool does not automatically mean true infection; first consider spurious passage from recently consumed infected liver.

Infectious Disease and Microbiology – Coxsackievirus Group

Overview

Coxsackieviruses are members of the enterovirus group and are divided mainly into coxsackievirus A and coxsackievirus B, each of which contains multiple serotypes.

They are common worldwide pathogens and are responsible for a wide range of clinical syndromes, including mucocutaneous disease, respiratory illness, myocarditis, meningitis, and neonatal disseminated infection.

Microbiologic Characteristics

Coxsackieviruses are:

• Single-stranded, positive-sense RNA viruses

• Nonenveloped (naked)

• Viruses with icosahedral symmetry

Because they are nonenveloped, they are relatively resistant to environmental conditions compared with enveloped viruses.

Epidemiology

Coxsackievirus infections occur worldwide and are a common cause of human illness.

Transmission is mainly through the fecal–oral route, although respiratory spread can also occur, particularly in syndromes involving the upper respiratory tract.

Children are commonly affected, but infection can occur at any age.

Hand-Foot-and-Mouth Disease

Coxsackievirus A is classically associated with hand-foot-and-mouth disease.

This syndrome is characterized by:

• Oral vesicles or ulcers

• Vesicular or papular lesions on the hands

• Lesions on the feet

• Fever

• Malaise

The mucosal lesions represent an enanthem, while the skin lesions represent an exanthem.

Herpangina

Herpangina is another classic coxsackievirus-associated syndrome.

It usually presents with:

• Fever

• Sore throat

• Painful vesicles or ulcers in the posterior oropharynx

• Difficulty swallowing

Coxsackievirus A is an important cause.

Upper Respiratory Tract Infection

Coxsackieviruses may produce nonspecific upper respiratory tract infections characterized by symptoms such as:

• Sore throat

• Rhinorrhea

• Cough

• Fever

• Malaise

Pleurodynia

Coxsackievirus B is classically associated with epidemic pleurodynia, also called Bornholm disease.

Patients may develop sudden episodes of:

• Severe chest pain

• Upper abdominal pain

• Fever

• Pain worsened by respiration or movement

The pain is related to inflammation of the chest wall and intercostal muscles.

Myopericarditis

Coxsackievirus B is an important viral cause of myocarditis and pericarditis.

Clinical manifestations may include:

• Chest pain

• Dyspnea

• Palpitations

• Arrhythmias

• Signs of heart failure

• Pericarditic pain

Severe myocarditis can occasionally result in substantial cardiac dysfunction.

Acute Hemorrhagic Conjunctivitis

Certain enteroviruses, including some coxsackievirus strains, may cause acute hemorrhagic conjunctivitis.

Patients may develop:

• Red eyes

• Eye discomfort

• Photophobia

• Conjunctival hemorrhage

• Excessive tearing

Central Nervous System Infection

Coxsackieviruses are important causes of aseptic meningitis.

They may also cause:

• Encephalitis

• Meningoencephalitis

• Rare paralytic syndromes

Neurologic infection may occur in both children and adults.

Chronic Meningoencephalitis

A particularly important complication can occur in severely immunocompromised patients, especially those with agammaglobulinemia.

These patients may develop chronic enteroviral meningoencephalitis because they lack adequate antibody-mediated immunity to control the infection.

Neonatal Disseminated Infection

Newborns can develop severe disseminated coxsackievirus infection.

This may involve multiple organs and can produce:

• Sepsis-like illness

• Myocarditis

• Hepatitis

• Meningoencephalitis

• Coagulopathy

• Shock

Neonatal disease may be rapidly progressive and life-threatening.

Diagnosis

Diagnosis can be established using:

• PCR

• Virologic culture

• Serologic testing

PCR is particularly useful for detecting enteroviral RNA in appropriate clinical specimens, including cerebrospinal fluid in suspected meningitis.

Treatment

Treatment is primarily supportive and symptomatic.

Management depends on the clinical syndrome and may include:

• Hydration

• Antipyretics and analgesics

• Cardiac monitoring for myocarditis

• Respiratory support when necessary

• Intensive supportive care in severe neonatal infection

Specific Antiviral Therapy

There is no routinely available specific antiviral treatment for most coxsackievirus infections.

Most uncomplicated infections resolve spontaneously.

Prevention

Prevention is based primarily on reducing transmission.

Important measures include:

• Careful hand hygiene

• Proper disposal of fecal material

• Avoiding close contact with infected secretions

• Enteric precautions during the contagious period

• Respiratory precautions when appropriate, such as during herpangina

Older recommendations include enteric isolation for approximately 1 week.

High-Yield Clinical Associations

Coxsackievirus A

→ Hand-foot-and-mouth disease

→ Herpangina

Coxsackievirus B

→ Pleurodynia

→ Myocarditis

→ Pericarditis

Both groups

→ Aseptic meningitis and other enteroviral syndromes

Exam Essentials

Group: Enterovirus

Genome: Positive-sense single-stranded RNA

Envelope: None

Capsid: Icosahedral

Distribution: Worldwide

Major syndromes: Hand-foot-and-mouth disease, herpangina, pleurodynia, myopericarditis, meningitis

Severe neonatal disease: Disseminated infection

High-risk chronic CNS disease: Agammaglobulinemia

Diagnosis: PCR, culture, serology

Treatment: Supportive

Specific antiviral: None routinely available

Prevention: Enteric and respiratory hygiene precautions

Key clinical pearl: The classic exam distinction is coxsackie A → hand-foot-and-mouth disease and herpangina, whereas coxsackie B → pleurodynia and myopericarditis.

Infectious Disease and Microbiology – Corynebacterium Species

Overview

Non-diphtherial Corynebacterium species are aerobic Gram-positive bacilli that are usually low-virulence organisms but can occasionally cause serious invasive disease. Important species include C. bovis, C. pilosum, C. pseudodiphtheriticum, C. striatum, and C. xerosis, among others.

These organisms are uncommon causes of infection, but they become more clinically significant in patients with neutropenia, prosthetic devices, or underlying cardiac disease.

Microbiologic Characteristics

Corynebacterium species are:

• Aerobic

• Gram-positive

• Bacillary organisms

Many species can colonize the skin or mucosal surfaces, which means that positive cultures must sometimes be interpreted carefully to distinguish true infection from contamination or colonization.

Epidemiology

These species are rare causes of human infection.

Clinically significant disease is more likely in patients with:

• Neutropenia

• Prosthetic heart valves

• Other implanted prosthetic material

• Severe underlying illness

• Prolonged hospitalization

Endocarditis

Non-diphtherial Corynebacterium species can cause infective endocarditis involving either:

• Native heart valves

• Prosthetic heart valves

Prosthetic valve infection is especially important because organisms may adhere to foreign material and become difficult to eradicate with antibiotics alone.

Septicemia

Septicemia is uncommon but occurs more frequently in neutropenic patients.

Patients may present with:

• Fever

• Chills

• Hypotension

• Persistent bacteremia

• Clinical evidence of sepsis

Repeated recovery of the same Corynebacterium species from blood cultures increases the likelihood that the isolate represents true infection rather than contamination.

Respiratory Tract Infections

These organisms can occasionally cause:

• Pneumonia

• Tracheitis

• Other respiratory tract infections

Respiratory disease is more likely in debilitated, hospitalized, or immunocompromised patients.

Prosthetic Material Infection

Corynebacterium species may infect implanted or prosthetic material.

Examples include:

• Prosthetic heart valves

• Vascular devices

• Orthopedic hardware

• Other implanted foreign bodies

Because biofilm formation and persistent colonization may occur, antimicrobial therapy alone may not always be sufficient.

Diagnosis

Diagnosis is made by culture from the appropriate clinical specimen.

Depending on the infection, samples may include:

• Blood cultures

• Respiratory specimens

• Tissue samples

• Prosthetic-device cultures

• Other sterile-site specimens

Clinical interpretation is important because some Corynebacterium species may be dismissed incorrectly as contaminants.

Treatment of Endocarditis

For severe endocarditis, a regimen described in the source is:

Vancomycin plus an aminoglycoside

This combination may be used initially in serious infection while awaiting susceptibility results.

Prosthetic Material Removal

When infection involves prosthetic material, removal of the infected device or prosthesis is frequently necessary.

Persistent infection despite apparently appropriate antimicrobial treatment should increase suspicion that the foreign material is acting as a continuing source.

Additional Antimicrobial Options

Therapy may need to be modified according to:

• Clinical response

• Site of infection

• Species identification

• In vitro susceptibility testing

Potential alternative agents include:

• Penicillin G

• Tetracycline

• Macrolides

• Rifampicin

• First-generation cephalosporins

• Teicoplanin

Treatment should be individualized because susceptibility patterns may vary among species.

High-Yield Clinical Pattern

Prosthetic valve or implanted device

• ●

Persistent bacteremia with a Corynebacterium species

• ●

Failure to clear infection with antibiotics alone

→ Consider true invasive Corynebacterium infection with infected prosthetic material

Exam Essentials

Genus: Corynebacterium

Type: Aerobic Gram-positive bacillus

Overall frequency: Rare cause of infection

Important syndromes: Endocarditis, septicemia, pneumonia, tracheitis, prosthetic-device infection

High-risk group for septicemia: Neutropenic patients

Diagnosis: Culture

Serious endocarditis treatment: Vancomycin plus an aminoglycoside

Important source-control measure: Removal of infected prosthetic material

Alternative agents: Penicillin G, tetracyclines, macrolides, rifampicin, first-generation cephalosporins, or teicoplanin

Key clinical pearl: When a non-diphtherial Corynebacterium species is repeatedly isolated from blood in a patient with a prosthetic valve, implanted device, or neutropenia, it should not automatically be dismissed as a contaminant.

Infectious Disease and Microbiology – Corynebacterium pseudotuberculosis

Overview

Corynebacterium pseudotuberculosis is an aerobic Gram-positive bacillus that primarily causes disease in animals and is only a rare cause of human infection. Human disease is usually associated with occupational or environmental exposure to infected animals.

The characteristic human manifestation is suppurative granulomatous lymphadenitis.

Microbiologic Characteristics

C. pseudotuberculosis is an aerobic, Gram-positive bacillus belonging to the genus Corynebacterium.

It is primarily an animal pathogen, with humans serving as accidental hosts following zoonotic exposure.

Epidemiology

Human infection is rare.

Most cases occur in people with significant contact with animals, particularly individuals whose occupations involve livestock or animal handling.

Potential exposure groups include:

• Farmers

• Veterinarians

• Abattoir workers

• Animal handlers

• Other individuals with close livestock exposure

Transmission

Human infection generally follows exposure to infected animals or contaminated animal material.

The organism may enter through breaks in the skin and subsequently spread through lymphatic channels to regional lymph nodes.

Suppurative Granulomatous Lymphadenitis

The classic human infection is suppurative granulomatous lymphadenitis.

Affected lymph nodes may become:

• Enlarged

• Painful or tender

• Inflamed

• Suppurative

• Chronically infected

The disease can resemble other causes of chronic granulomatous lymphadenopathy.

Differential Diagnosis

Important alternative causes of chronic or suppurative lymphadenitis include:

• Tuberculosis

• Nontuberculous mycobacterial infection

• Cat-scratch disease

• Tularemia

• Fungal infection

• Other bacterial lymphadenitis

A history of animal exposure provides an important clue to C. pseudotuberculosis infection.

Diagnosis

Definitive diagnosis is established by culture of material obtained from the infected lymph node or another appropriate specimen.

The organism can be cultured on:

Blood agar incubated with approximately 10% CO₂

Microbiologic identification is important because the clinical appearance can mimic several other causes of granulomatous lymphadenitis.

Treatment

Macrolide antibiotics may be used for C. pseudotuberculosis infection.

Treatment is often combined with appropriate management of the infected lymph nodes.

Surgical Management

Excision of infected lymph nodes may be necessary, particularly when lymphadenitis is persistent, suppurative, or inadequately responsive to antimicrobial therapy.

Thus, effective management may require both:

Antimicrobial therapy + surgical excision

Additional Treatment

Alternative antimicrobial agents include:

• Tetracyclines

• Penicillin G

Whenever possible, treatment of significant infection should be guided by culture and antimicrobial susceptibility results.

High-Yield Clinical Pattern

Animal or livestock exposure

• ●

Chronic enlarged lymph nodes

• ●

Suppurative granulomatous lymphadenitis

→ Think Corynebacterium pseudotuberculosis

Exam Essentials

Organism: Corynebacterium pseudotuberculosis

Type: Aerobic Gram-positive bacillus

Transmission: Zoonotic exposure, usually involving animals

Human infection: Rare

Classic manifestation: Suppurative granulomatous lymphadenitis

Diagnosis: Culture

Culture condition: Blood agar with approximately 10% CO₂

Treatment: Macrolide antibiotic

Source control: Excision of infected lymph nodes when indicated

Alternatives: Tetracycline or penicillin G

Key clinical pearl: The combination of animal exposure and chronic suppurative granulomatous lymphadenitis should raise suspicion for Corynebacterium pseudotuberculosis.